United States

People: Sol Gel Technologies Ltd (SLGL.OQ)

SLGL.OQ on NASDAQ Stock Exchange Global Market

18 Apr 2019
Change (% chg)

$-0.14 (-1.96%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Levy-Hacham, Ofra 

Dr. Ofra Levy-Hacham is Vice President - Quality and Regulatory Affairs of Sol-Gel Technologies Ltd. She manages Sol-Gel’s quality systems and compliance initiatives. Dr. Levy-Hacham is an experienced specialist in manufacturing control, QA and QC management, drug discovery and regulatory affairs. Before joining Sol-Gel, Dr. Levy-Hacham was VP of CMC at HealOr Ltd., senior positions in the QA of Bio-Technology General and other pharmaceutical companies. Dr. Levy-Hacham received her PhD in Chemistry from the Faculty of Chemistry, Technion Haifa, Israel.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --